Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72
- 296 Downloads
The acute, as well as late, phase of cardioprotection induced by ischemic preconditioning is abolished in hyperlipidemic (HL) rat heart. The pharmacological inhibition of glycogen synthase kinase-3β (GSK-3β), has earlier been reported to restore this attenuated acute cardioprotective effect. However, it not known whether GSK-3β inhibitors administered 24 h before the ischemic injury would restore the late cardioprotective in HL rat and, if yes, the role of heat shock protein 72 (HSP 72) in its modulation. Hyperlipidemia was produced in rat by feeding high-fat diet for 6 weeks. Isolated perfused rat heart was subjected to 30 min of ischemia followed by 120 min of reperfusion (I/R). Myocardial infarct size was estimated by triphenyltetrazolium chloride staining, while lactate dehydrogenase (LDH) and creatine kinase-MB (CK-MB) levels were analyzed from coronary effluent. GSK-3β inhibitors, SB 216763 (SB, 0.6 mg/kg, i.p.), and indirubin-3 monoxime (IND, 0.4 mg/kg, i.p.), administered 24 h before the isolation of heart, significantly decreased the I/R-induced myocardial infarct size and the release of LDH and CK-MB. The cardioprotective effect of GSK-3β inhibitors was significantly attenuated by quercetin (4 mg/kg, i.p.), a HSP 72 inhibitor, administered 1 h before the administration of SB or IND. That the late phase of cardioprotection induced by pretreatment with GSK-3β inhibitors is not attenuated/lost in HL rat heart is a new finding in our study. Our results indicate that HSP 72 acts on pathway of GSK-3β and plays a significant role in cardioprotection.
KeywordsGlycogen synthase kinase-3β Ischemic preconditioning Hyperlipidemia
No external source of funding was used in this study.
- 2.Juhaszaova M, Zorov DB, Kim SH, Pepe SFuQ, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, lson EN, Sollott SJ (2004) Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113:1535–1549Google Scholar
- 9.Snoeckx IH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, van der Vusse GJ (2001) Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 81:1461–1497Google Scholar
- 12.Karmazyn M, Mailer K, Currie RW (1990) Acquisition and decay of heat-shock-enhanced post-ischemic ventricular recovery. Am J Physiol Heart Circ Physiol 259:H424–H431Google Scholar
- 22.Chu B, Zhong R, Soncin F, Stevenson MA, Calderwood SK (1998) Transcriptional activity of heat shock factor 1 at 37 °C is repressed through phosphorylation on two distinct serine residues by glycogen synthase kinase 3 and protein kinases Cα and Cζ. J Biol Chem 273:18640–18646PubMedCrossRefGoogle Scholar
- 24.Bijur GF, Jope RS (2000) Opposing actions of phospahtidylinositol 3-kinase and glycogen synthase kinase-3 beta in the regulation of HSF-1. Neurochemistry 75:2401–2408Google Scholar
- 44.Liu J, Kam KWL, Zhou J, Yan W, Chen M, Wu S, Wong TM (2004) Effects of heat shock protein 70 activation by metabolic inhibition preconditioning or к-opioid receptor stimulation on Ca2+ homeostasis in rat ventricular myocytes subjected to ischemic insults. J Pharmacol Exp Ther 310:606–613PubMedCrossRefGoogle Scholar